期刊文献+

蝮蛇毒蛋白C激活物对全脑缺血再灌注损伤大鼠血-脑屏障通透性的影响

Effect of Agkistrodon halys Pallas Venom protein C activator on permeability of blood-brain barrier in total cerebral ischemia-reperfusion injury rats
原文传递
导出
摘要 目的探讨蝮蛇毒蛋白C激活物(PCA)对全脑缺血再灌注损伤大鼠血-脑屏障通透性的影响和可能的机制。方法以关闭和重开放双侧颈总动脉和基底动脉来复制大鼠全脑缺血再灌注损伤模型。按照体重将SD大鼠随机分为5组:假手术组、模型组和低、中、高3个剂量实验组,每组10只。于造模前,低、中、高3个剂量实验组分别尾静脉注射PCA 1,3,6 mg·kg-1,假手术组和模型组给予等量0.9%NaCl。用试剂盒法检测大鼠血清肿瘤坏死因子α(TNF-α)含量;以酶联免疫吸附法检测大鼠脑组织细胞间黏附分子-1(ICAM-1);以伊文思蓝(EB)染色法观察大鼠血脑-屏障通透性。结果假手术组、模型组和低、中、高3个剂量实验组的TNF-α分别为(5.57±1.81),(25.37±1.96),(15.32±1.94),(13.31±1.79)和(10.47±1.71)pg·mg-1;这5组的ICAM-1分别为(56.80±5.96),(105.80±10.23),(76.60±5.56),(63.50±8.34)和(59.10±8.36) ng·mL-1;这5组的EB含量分别为(0.55±0.18),(1.61±0.19),(0.99±0.22),(0.72±0.18)和(0.54±0.09)μg·g-1。上述指标:模型组与假手术组比较,差异均有统计学意义(均P<0.01);低、中、高3个剂量实验组与模型组比较,差异均有统计学意义(均P<0.01),且随着PCA浓度的增加,效果越明显。结论 PCA可降低脑缺血再灌注损伤大鼠血-脑屏障的通透性,其机制可能与抑制炎症细胞因子、下调细胞黏附分子和减轻炎症反应有关。 Objective To investigate the effects of protein C activator(PCA)from Agkistrodon halys Pallas Venom on permeabiluty of blood-brain barrier in total cerebral ischemia-reperfusion injury rats and explore possible mechanisms. Methods Total cerebral ischemia-reperfusion injury model was established by closuring and re-opening the bilateral common carotid artery and basilar artery. Sprague-Dawley(SD) rats were randomly divided into five groups:sham-operation group,model group and experimental-L,-M,-H groups,ten rats in each group. experimental-L,-M,-H groups were given 1,3 and 6 mg·kg-1PCA respectively by the tail vein before copying model,while the sham operation group and the model group were given equal amount of 0.9%NaCl. Levels of tumor necrosis factor-α(TNF-α) in serum were detected by Kit. The content of intercellular adhersion molecule-1(ICAM-1) in brain tissue was detected by enzyme-linked immunosorbent assay. And the permeability of blood-brain barrier in rats was observed by Evans blue(EB) staining. Results Level of TNF-α in sham operation group,model group and low,middle,high dose experimental groups were(5. 57 ± 1. 81),(25. 37 ± 1. 96),(15. 32 ± 1. 94),(13. 31 ± 1. 79),(10. 47 ± 1. 71)pg·mg-1;the ICAM-1 level in the five groups were(56. 80 ± 5. 96),(105. 80 ± 10. 23),(76. 60 ± 5. 56),(63. 50 ± 8. 34),(59. 10 ± 8. 36) ng·mL-1;EB contents in the five groups were(0. 55 ± 0. 18),(1. 61 ± 0. 19),(0. 99 ± 0. 22),(0. 72 ± 0. 18),(0. 54 ± 0. 09) μg·g-1. Compared between model group and sham operation group,the difference of the factors were significant(all P < 0. 01);compared between experimental group and model group,the difference of the factors were significant(all P < 0. 01). And with the increase of PCA concentration,the effect was more obvious. Conclusion PCA can reduce the permeability of blood-brain barrier in rats with cerebral ischemia reperfusion injury. Its mechanism may be related to inhibiting inflammatory cytokines,down-regulating cell adhesion molecules,and reducing inflammatory response.
作者 张阳 陈瑞 刘迪 高云星 ZHANG Yang;CHEN Rui;LIU Di;GAO Yun-xing(Experimental Training Center of Clinical Medicine,Wannan Medical College,Wuhu 241001,Anhui Province,China;School of Clinical Medicine,Wannan Medical College,Wuhu 241001,Anhui Province,China;Department of Microbiology,Wannan Medical College,Wuhu 241001,Anhui Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2020年第16期2404-2407,共4页 The Chinese Journal of Clinical Pharmacology
基金 安徽省教育厅自然科学重点基金资助项目(KJ2019A0419) 安徽省重点实验室自主活性生物大分子研究课题基金资助项目(LAB201402) 大学生创新创业训练计划基金资助项目(201810368028)。
关键词 蝮蛇毒 蛋白C激活物 全脑缺血再灌注损伤 炎症细胞因子 细胞黏附分子 血-脑屏障 Agkistrodon halys Pallas Venom protein C activator total cerebral ischemia-reperfusion injury inflammatory cytokine cell adhesion molecule blood-brain barrier
  • 相关文献

参考文献6

二级参考文献42

  • 1张闻多,丁文惠.细胞凋亡与凋亡诱导因子[J].中国病理生理杂志,2006,22(9):1858-1862. 被引量:17
  • 2Kirino T. Delayed neuronal death in the gerbi! hippocam- pus following ischemia [ J ]. Brain Res, 1982, 239 ( 1 ) : 57 -69.
  • 3Kokubo Y, Iso H, Ishihara J, et al. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations : the Ja- pan Public Health Center-based (JPHC) study cohort I [J]. Circulation, 2007, 116(22) :2553-2562.
  • 4Messina M. A brief historical overview of the past two dec- ades of soy and isoflavone research [ J ]. J Nutr, 2010, 140(7) : 1350S-1354S.
  • 5Qian Y, Guan T, Huang M, et al. Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria- dependent apoptosis pathways and reactive oxygen in- duced-NF-κB activation in a cerebral ischemia mouse mo- del[J]. Neurochem Int, 2012, 60(8):759-767.
  • 6Rao VK, Carlson EA, Yan SS. Mitochondrial permeability transition pore is a potential drug target for neurodegenera- tion[ J]. Biochim Biophys Acta, 2014, 1842 (8): 1267-1272.
  • 7Hockenbery D, Nufiez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks pro- grammed cell death [ J ]. Nature, 1990, 348 ( 6299 ) : 334-336.
  • 8Friedlander RM. Apoptosis and caspases in neurodegene- rative diseases [ J ]. N Engl J Med, 2003, 348 ( 14 ) : 1365-1375.
  • 9Slee EA, Harte MT, Kluck RM, et al. Ordering the eyto- chrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-de- pendent manner [J]. J Cell Bid, 1999, 144 (2): 281-292.
  • 10Christophe M, Nicolas S. Mitochondria: a target for neu- roprotective interventions in cerebral ischemia-reperfusion [J]. Curr Pharm Des, 2006, 12(6) :739-757.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部